ArticleEmerging microbes & infections2021

Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model.

Ha-Na Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.